Hepion Pharmaceuticals Inc (HEPA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,227 | -7,037 | -4,824 | -3,005 | -1,984 |
| Depreciation Amortization | 7 | 513 | 507 | 500 | 74 |
| Income taxes - deferred | N/A | 48 | N/A | N/A | N/A |
| Other Working Capital | -506 | -826 | -611 | -710 | -154 |
| Other Operating Activity | 48 | -263 | -196 | -107 | 5 |
| Operating Cash Flow | $-4,678 | $-7,565 | $-5,125 | $-3,322 | $-2,058 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 2 | -52 | -45 | -45 | -38 |
| Investing Cash Flow | $2 | $-52 | $-45 | $-45 | $-38 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 1,250 |
| Debt Repayment | N/A | -1,119 | -2,036 | -304 | N/A |
| Common Stock Issued | 6,801 | 19,827 | 17,988 | 17,988 | N/A |
| Other Financing Activity | 0 | 0 | 1,250 | 0 | -304 |
| Financing Cash Flow | $6,801 | $18,707 | $17,202 | $17,684 | $947 |
| Beginning Cash Position | 13,923 | 2,832 | 2,832 | 2,832 | 2,832 |
| End Cash Position | 16,048 | 13,923 | 14,864 | 17,149 | 1,683 |
| Net Cash Flow | $2,125 | $11,091 | $12,032 | $14,317 | $-1,150 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,678 | -7,565 | -5,125 | -3,322 | -2,058 |
| Capital Expenditure | N/A | -52 | -45 | -45 | -38 |
| Free Cash Flow | -4,678 | -7,617 | -5,170 | -3,367 | -2,096 |